+ |
warfarin | down-regulates activity
chemical inhibition
|
VKORC1 |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265911 |
|
|
Homo sapiens |
|
pmid |
sentence |
27941861 |
Warfarin and vitamin K compete for binding to Phe55 in human VKOR|Our results challenge the prevailing concept of noncompetitive warfarin inhibition because K vitamers and warfarin share binding sites on VKOR that include Phe55, a key residue binding either the substrate or inhibitor. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Vitamin-K cycle |
+ |
VKORC1 | down-regulates quantity
chemical modification
|
vitamin K epoxide |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265900 |
|
|
Homo sapiens |
|
pmid |
sentence |
31226734 |
The epoxide form of vitamin K is reduced by epoxide reductase (vitamin K epoxide reductase complex 1; VKORC1 or vitamin K epoxide reductase complex 1-like 1; VKORC1L1) to a reduced form and then to the reduced hydroquinone form |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Vitamin-K cycle |
+ |
VKORC1 | down-regulates quantity
chemical modification
|
vitamin K |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265904 |
|
|
Homo sapiens |
|
pmid |
sentence |
31226734 |
This series of oxidation-reduction reactions begins with conversion of vitamin K from a stable oxidized form (quinone form) to a hydroquinone form by vitamin K epoxide reductase (VKOR) |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Vitamin-K cycle |
+ |
VKORC1 | up-regulates quantity
chemical modification
|
Reduced Vitamin K |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265905 |
|
|
Homo sapiens |
|
pmid |
sentence |
31226734 |
This series of oxidation-reduction reactions begins with conversion of vitamin K from a stable oxidized form (quinone form) to a hydroquinone form by vitamin K epoxide reductase (VKOR) |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265901 |
|
|
Homo sapiens |
|
pmid |
sentence |
31226734 |
The epoxide form of vitamin K is reduced by epoxide reductase (vitamin K epoxide reductase complex 1; VKORC1 or vitamin K epoxide reductase complex 1-like 1; VKORC1L1) to a reduced form and then to the reduced hydroquinone form |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
Pathways: | Vitamin-K cycle |